Mavacamten for use in the treatment of hypertrophic cardiomyopathy

MYPI2025004921A0Undetermined Publication Date: 2019-02-04MYOKARDIA INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025004921
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2018-05-15
Filing Date
2018-08-03
Publication Date
2019-02-04
Patent Text Reader

Abstract

Provided are methods for treating hypertrophic cardiomyopathy and diastolic dysfunction. [No suitable figure]
Need to check novelty before this filing date? Find Prior Art